AAAAAA

   
Results: 1-25 | 26-50
Results: 1-25/50
EFFECT OF AGE, SEX, ORAL-CONTRACEPTIVES AND VITAMIN SUPPLEMENTS ON THE SERUM TOTAL HOMOCYSTEINE CONCENTRATION
Authors: CALLAS DD BERMES EW OESER T KAHN SE HOLMES EW
Citation: Dd. Callas et al., EFFECT OF AGE, SEX, ORAL-CONTRACEPTIVES AND VITAMIN SUPPLEMENTS ON THE SERUM TOTAL HOMOCYSTEINE CONCENTRATION, Clinical chemistry, 44, 1998, pp. 583-583
PHARMACOKINETICS OF THE COMPARATIVE TFPI RELEASE BY LOW-MOLECULAR-WEIGHT HEPARINS (LMWHS) AS MEASURED BY USING A HIGHLY SENSITIVE ELISA METHOD
Authors: FASANELLA A HOPPENSTEADT D WOLF H BERMES EW
Citation: A. Fasanella et al., PHARMACOKINETICS OF THE COMPARATIVE TFPI RELEASE BY LOW-MOLECULAR-WEIGHT HEPARINS (LMWHS) AS MEASURED BY USING A HIGHLY SENSITIVE ELISA METHOD, Thrombosis and haemostasis, 1997, pp. 1672-1672
IN-VITRO EFFECTS OF A NOVEL HEMOGLOBIN-BASED OXYGEN CARRIER ON ROUTINE CHEMISTRY, THERAPEUTIC DRUG, COAGULATION, HEMATOLOGY, AND BLOOD-BANKASSAYS
Authors: CALLAS DD CLARK TL MOREIRA PL LANSDEN C GAWRYL MS KAHN S BERMES EW
Citation: Dd. Callas et al., IN-VITRO EFFECTS OF A NOVEL HEMOGLOBIN-BASED OXYGEN CARRIER ON ROUTINE CHEMISTRY, THERAPEUTIC DRUG, COAGULATION, HEMATOLOGY, AND BLOOD-BANKASSAYS, Clinical chemistry, 43(9), 1997, pp. 1744-1748
CLINICAL UTILITY OF CARDIAC TROPONIN-I MEASUREMENTS IN THE DIAGNOSIS OF ACUTE MYOCARDIAL-INFARCTION AND IMPLEMENTATION OF THEIR USE IN AN ACADEMIC-MEDICAL-CENTER
Authors: KAHN SE WARD KA GALBRAITH KA CALLAS DD BANGAYAN L AUGUSTINE GA BERMES EW
Citation: Se. Kahn et al., CLINICAL UTILITY OF CARDIAC TROPONIN-I MEASUREMENTS IN THE DIAGNOSIS OF ACUTE MYOCARDIAL-INFARCTION AND IMPLEMENTATION OF THEIR USE IN AN ACADEMIC-MEDICAL-CENTER, Clinical chemistry, 43, 1997, pp. 66-66
REPORT OF THE 3RD CONFERENCE ON EDUCATION IN CLINICAL-CHEMISTRY
Authors: WU AHB BERMES EW
Citation: Ahb. Wu et Ew. Bermes, REPORT OF THE 3RD CONFERENCE ON EDUCATION IN CLINICAL-CHEMISTRY, Clinical chemistry, 43(1), 1997, pp. 167-173
INHIBITION OF IFNY INDUCED INDOLEAMINE DIOXYGENASE (IDO) BY CA IONOPHORE, SPHINGOLIPIDS, AND NSAIDS
Authors: HOLMES EW BERMES EW
Citation: Ew. Holmes et Ew. Bermes, INHIBITION OF IFNY INDUCED INDOLEAMINE DIOXYGENASE (IDO) BY CA IONOPHORE, SPHINGOLIPIDS, AND NSAIDS, The FASEB journal, 10(6), 1996, pp. 2501-2501
EVALUATION OF THE STA AUTOMATED ANALYZER FOR HEMOSTASIS TESTING
Authors: WALENGA JM HOPPENSTEADT DA GRYZBAC M MAY K BLAKEMORE C MANABAT N MOLNAR J BERMES EW
Citation: Jm. Walenga et al., EVALUATION OF THE STA AUTOMATED ANALYZER FOR HEMOSTASIS TESTING, Clinical chemistry, 42(6), 1996, pp. 224-224
DIAGNOSTIC-VALUE OF TROPONIN-T AS A MARKER OF MYOCARDIAL INJURY IN ACUTE AND CHRONIC CORONARY SYNDROMES
Authors: KAHN S WOLF H HOPPENSTEADT DA WALENGA JM GALBRAITH E BERMES EW FAREED J
Citation: S. Kahn et al., DIAGNOSTIC-VALUE OF TROPONIN-T AS A MARKER OF MYOCARDIAL INJURY IN ACUTE AND CHRONIC CORONARY SYNDROMES, Clinical chemistry, 42(6), 1996, pp. 330-330
PHARMACOKINETICS (PK) OF THE COMPARATIVE TFPI RELEASE BY LOW-MOLECULAR-WEIGHT HEPARINS (LMWHS) AS MEASURED BY USING A HIGHLY SENSITIVE ELISA METHOD
Authors: FASANELLA A HOPPENSTEADT DA WOLF H BERMES EW FAREED J
Citation: A. Fasanella et al., PHARMACOKINETICS (PK) OF THE COMPARATIVE TFPI RELEASE BY LOW-MOLECULAR-WEIGHT HEPARINS (LMWHS) AS MEASURED BY USING A HIGHLY SENSITIVE ELISA METHOD, Clinical chemistry, 42(6), 1996, pp. 409-409
SPECIFIC QUANTITATION OF HEPARIN-RELEASABLE MULTIDOMAIN KUNITZ-TYPE INHIBITOR (TFPI) DURING PROPHYLACTIC AND THERAPEUTIC USE OF ANTICOAGULANTS
Authors: JESKE W HOPPENSTEADT D BERMES EW FASANELLA A FAREED J
Citation: W. Jeske et al., SPECIFIC QUANTITATION OF HEPARIN-RELEASABLE MULTIDOMAIN KUNITZ-TYPE INHIBITOR (TFPI) DURING PROPHYLACTIC AND THERAPEUTIC USE OF ANTICOAGULANTS, Clinical chemistry, 42(6), 1996, pp. 410-410
EFFECT OF A GLYCOPROTEIN IIB IIIA INHIBITOR ON PLATELET ACTIVATION AND AGGREGATION AS MEASURED BY AGGREGOMETRY AND WHOLE-BLOOD FLOW-CYTOMETRY/
Authors: KOZA MJ HOPPENSTEADT DA WALENGA JM FAREED J BERMES EW PIFARRE R
Citation: Mj. Koza et al., EFFECT OF A GLYCOPROTEIN IIB IIIA INHIBITOR ON PLATELET ACTIVATION AND AGGREGATION AS MEASURED BY AGGREGOMETRY AND WHOLE-BLOOD FLOW-CYTOMETRY/, Clinical chemistry, 42(6), 1996, pp. 411-411
MEASUREMENT OF THE ANTICOAGULANT EFFECT OF WARFARIN IN THE PRESENCE OF AN ANTITHROMBIN AGENT USING AMIDOLYTIC FACTOR-X ASSAY
Authors: KOZA MJ WALENGA JM HOPPENSTEADT DA BERMES EW FAREED J
Citation: Mj. Koza et al., MEASUREMENT OF THE ANTICOAGULANT EFFECT OF WARFARIN IN THE PRESENCE OF AN ANTITHROMBIN AGENT USING AMIDOLYTIC FACTOR-X ASSAY, Clinical chemistry, 42(6), 1996, pp. 412-412
MOLECULAR MARKERS OF HEMOSTATIC AND VASCULAR ABBERATIONS IN THE ELDERLY AND THEIR PREDICTIVE VALUE FOR THE DIAGNOSIS OF THROMBOTIC DISORDERS
Authors: IQBAL O HOPPENSTEADT DA KOZA MJ BERMES EW WALENGA JM FAREED J
Citation: O. Iqbal et al., MOLECULAR MARKERS OF HEMOSTATIC AND VASCULAR ABBERATIONS IN THE ELDERLY AND THEIR PREDICTIVE VALUE FOR THE DIAGNOSIS OF THROMBOTIC DISORDERS, Clinical chemistry, 42(6), 1996, pp. 413-413
ANTIBODIES AGAINST BETA(2)-GLYCOPROTEIN-I IN ANTICARDIOLIPIN CALIBRATORS
Authors: WEI TQ BERMES EW JANDRESKI MA
Citation: Tq. Wei et al., ANTIBODIES AGAINST BETA(2)-GLYCOPROTEIN-I IN ANTICARDIOLIPIN CALIBRATORS, Clinical chemistry, 42(4), 1996, pp. 642-643
PHARMACOKINETICS (PK) OF THE COMPARATIVE TFPI RELEASE BY LOW-MOLECULAR-WEIGHT HEPARINS (LWMHS) AS MEASURED BY USING A HIGHLY SENSITIVE ELISA METHOD
Authors: FASANELLA A HOPPENSTEADT D WOLF H BERMES EW FAREED J
Citation: A. Fasanella et al., PHARMACOKINETICS (PK) OF THE COMPARATIVE TFPI RELEASE BY LOW-MOLECULAR-WEIGHT HEPARINS (LWMHS) AS MEASURED BY USING A HIGHLY SENSITIVE ELISA METHOD, Blood, 88(10), 1996, pp. 3050-3050
MOLECULAR MARKERS OF HEMOSTATIC ACTIVATION - APPLICATIONS IN THE DIAGNOSIS OF THROMBOSIS AND VASCULAR AND THROMBOTIC DISORDERS
Authors: FAREED J BICK RL HOPPENSTEADT DA BERMES EW
Citation: J. Fareed et al., MOLECULAR MARKERS OF HEMOSTATIC ACTIVATION - APPLICATIONS IN THE DIAGNOSIS OF THROMBOSIS AND VASCULAR AND THROMBOTIC DISORDERS, Clinical and applied thrombosis/hemostasis, 1(2), 1995, pp. 87-102
TISSUE FACTOR ANTIGEN LEVELS IN VARIOUS BIOLOGICAL-FLUIDS
Authors: FAREED J CALLAS DD HOPPENSTEADT D BERMES EW
Citation: J. Fareed et al., TISSUE FACTOR ANTIGEN LEVELS IN VARIOUS BIOLOGICAL-FLUIDS, Blood coagulation & fibrinolysis, 6, 1995, pp. 32-36
THE ROLE OF TISSUE FACTOR PATHWAY INHIBITOR IN THE MEDIATION OF THE ANTITHROMBOTIC ACTIONS OF HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN
Authors: HOPPENSTEADT DA JESKE W FAREED J BERMES EW
Citation: Da. Hoppensteadt et al., THE ROLE OF TISSUE FACTOR PATHWAY INHIBITOR IN THE MEDIATION OF THE ANTITHROMBOTIC ACTIONS OF HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN, Blood coagulation & fibrinolysis, 6, 1995, pp. 57-64
NSAIDS MODULATE INTERFERON-GAMMA-INDUCED OXIDATIVE TRYPTOPHAN-METABOLISM IN FIBROBLASTS
Authors: HOLMES EW BERMES EW
Citation: Ew. Holmes et Ew. Bermes, NSAIDS MODULATE INTERFERON-GAMMA-INDUCED OXIDATIVE TRYPTOPHAN-METABOLISM IN FIBROBLASTS, The FASEB journal, 9(4), 1995, pp. 954-954
THE ROLE OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) IN THE MEDIATION OF THE ANTITHROMBOTIC ACTIONS OF HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN
Authors: HOPPENSTEADT D KOZA M WALENGA JM LEYA F PIFARRE R BERMES EW
Citation: D. Hoppensteadt et al., THE ROLE OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) IN THE MEDIATION OF THE ANTITHROMBOTIC ACTIONS OF HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN, Thrombosis and haemostasis, 73(6), 1995, pp. 944-944
GLYCOPROTEIN-IIB IIIA INHIBITOR ON PLATELET-AGGREGATION AND ACTIVATION AS DETERMINED BY PLATELET AGGREGOMETRY AND FLOW CYTOMETRIC ANALYSIS/
Authors: KOZA MJ HOLNESS S WALENGA JM SHANKEY TV REILLY T BERMES EW PIFARRE R
Citation: Mj. Koza et al., GLYCOPROTEIN-IIB IIIA INHIBITOR ON PLATELET-AGGREGATION AND ACTIVATION AS DETERMINED BY PLATELET AGGREGOMETRY AND FLOW CYTOMETRIC ANALYSIS/, Thrombosis and haemostasis, 73(6), 1995, pp. 996-996
TISSUE FACTOR IS CAPABLE OF ACTIVATING CYCLOOXYGENASE COMPROMISED PLATELETS - IMPLICATIONS IN INTERVENTIONAL CARDIOVASCULAR PROCEDURES
Authors: KOZA MJ WALENGA JM SHANKEY TV FAREED J BERMES EW PIFARRE R
Citation: Mj. Koza et al., TISSUE FACTOR IS CAPABLE OF ACTIVATING CYCLOOXYGENASE COMPROMISED PLATELETS - IMPLICATIONS IN INTERVENTIONAL CARDIOVASCULAR PROCEDURES, Thrombosis and haemostasis, 73(6), 1995, pp. 997-997
FISH SKIN GLYCOSAMINOGLYCANS - A SOURCE FOR HIGHLY-ACTIVE HEAVILY SULFATED CHONDROITIN SULFATES
Authors: COYNE E MESSMORE H WALENGA JM HOPPENSTEADT D FARID S WEHRMACHER W BERMES EW
Citation: E. Coyne et al., FISH SKIN GLYCOSAMINOGLYCANS - A SOURCE FOR HIGHLY-ACTIVE HEAVILY SULFATED CHONDROITIN SULFATES, Thrombosis and haemostasis, 73(6), 1995, pp. 1351-1351
MOLECULAR MARKERS OF HEMOSTATIC ACTIVATION - IMPLICATIONS IN THE DIAGNOSIS OF THROMBOSIS, VASCULAR, AND CARDIOVASCULAR DISORDERS
Authors: FAREED J BICK RL HOPPENSTEADT DA WALENGA JM MESSMORE HL BERMES EW
Citation: J. Fareed et al., MOLECULAR MARKERS OF HEMOSTATIC ACTIVATION - IMPLICATIONS IN THE DIAGNOSIS OF THROMBOSIS, VASCULAR, AND CARDIOVASCULAR DISORDERS, Clinics in laboratory medicine, 15(1), 1995, pp. 39-61
TISSUE FACTOR (TF) AND HEPARIN-RELEASABLE TISSUE FACTOR PATHWAY INHIBITOR (TFPI) DURING INTERVENTIONAL CARDIOVASCULAR PROCEDURES
Authors: WALENGA JM HOPPENSTEADT D KOZA M FAREED J PIFARRE R BERMES EW
Citation: Jm. Walenga et al., TISSUE FACTOR (TF) AND HEPARIN-RELEASABLE TISSUE FACTOR PATHWAY INHIBITOR (TFPI) DURING INTERVENTIONAL CARDIOVASCULAR PROCEDURES, Clinical chemistry, 41(6), 1995, pp. 55-56
Risultati: 1-25 | 26-50